DALLAS, March 2, 2020 /PRNewswire/ -- #stayfactual. There is a lot of misinformation out there regarding coronavirus – some intentional, some unintentional. It is important that people take care to separate fact from fiction.

FORT LAUDERDALE, Fla., March 2, 2020 /PRNewswire/ -- Q'STRAINT, a recognized global leader of mobility passenger safety solutions, announce the release of the QUANTUM GEN II, a continuat

WASHINGTON and TEANECK, N.J., March 2, 2020 /PRNewswire/ -- Medicomp Systems, the leading provider of clinician-driven, point-of-care solutions that fix EHRs, and Holy Name Health, a comprehensive 361-bed acute care facility providing compassionate and personalized care, today announced the unveiling of Harmony EHR, a new solution de

ALEXANDRIA, Va., March 2, 2020 /PRNewswire/ -- The US Army has mandated that all soldiers (nurses, engineers, etc.) be able to pass the Army Combat Fitness Test by October 2020.  There are no special accommodations for women, nor are there any exceptions for soldiers in their 50s and 60s.

BRIDGEWATER, N.J., March 2, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Sarclisa® (isatuximab-irfc) in combination with pomalidomide and dexamethasone (pom-dex) for the treatment of adults with relapsed refractory multiple myeloma (RRMM) who have received at least two prior therapies including lenalidomide and a proteasome

NEW YORK, March 2, 2020 /PRNewswire/ -- Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease, announces it will be presenting

WASHINGTON, March 2, 2020 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, announced today that Jeanne Regnante, a long-time healthcare and global patient engagement professional, has joined the Foundation as Chief Health Equity and Diversity Officer.

WASHINGTON, March 2, 2020 /PRNewswire/ -- For the third consecutive year, Children's National Hospital was selected to compete in STAT Madness, an ann

FITCHBURG, Mass., March 2, 2020 /PRNewswire/ --

SONGDO, South Korea, March 2, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and STCube announced a strategic development and manufacturing service agreement for STT-003 antibody, an anti-cancer drug candidate. Under the agreement, Samsung Biologics will offer a wide range of services from cell line development, process development, manufacturing of non-c